DEVELOPMENT OF A PROTOCOL FOR WHOLE GENOME SEQUENCING OF THE SARS-COV-2 VIRUS

2022

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.26577/eb.2022.v92.i3.08
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Whole-genome sequencing of the SARS-CoV-2 virus during the pandemic has become an essential part of the epidemiological control of the spread of coronavirus infection. This made it possible to get actual data of circulating genetic variants and mutational changes of SARS-CoV-2 during the pandemic. The obtained results provided an opportunity for researchers to collect additional data to evaluate the virulence, infectivity, and the likelihood of evading an immune response when using vaccines and therapeutic monoclonal antibodies. There are different technological approaches for whole-genome sequencing of SARS-CoV-2, but multiplex PCR amplification is used most often due to ease of implementation and cost-effectiveness. When performing research on viral genome sequencing, researchers need to optimize existing sequencing protocols with available reagents or develop new approaches. This study is devoted to the development of a protocol for whole-genome sequencing of the SARS-CoV-2 virus based on the use of RT-PCR amplification using 39 primer pairs in 3 reaction mixtures. The protocol made it possible to obtain 15 complete genome data of the SARS-CoV-2 and can probably be used for large-scale studies on viral genome sequencing.